PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsSab378
Sab378
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
217 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Marijuana abuseD002189EFO_0007191F124332511887
CannabisD002188——2517111049
Multiple sclerosisD009103EFO_0003885G3524181123
SclerosisD012598———2171—19
Muscle spasticityD009128——23121—16
Alcohol drinkingD000428EFO_0004329—1——124
Cocaine-related disordersD019970—F14———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PainD010146EFO_0003843R527515—229
NeuralgiaD009437EFO_0009430—367—215
NeoplasmsD009369—C80346—314
Peripheral nervous system diseasesD010523—G64125——7
Anxiety disordersD001008EFO_0006788F41.1—21—35
AnxietyD001007EFO_0005230F41.1—21—35
Chronic painD059350——121—15
Post-traumatic stress disordersD013313EFO_0001358F43.1221—14
DementiaD003704EFO_0003862F03—41——4
Spinal cord injuriesD013119EFO_1001919—211——3
Show 26 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Driving under the influenceD000066448——44——39
Marijuana useD000074609——32——16
Alcoholic intoxicationD000435——31——14
GlioblastomaD005909EFO_0000515—33———4
Marijuana smokingD008385———4———4
Alzheimer diseaseD000544EFO_0000249F0313———3
Tobacco useD064424—Z72.012———3
Migraine disordersD008881EFO_0003821G43—2———2
Parkinson diseaseD010300EFO_0002508G20—2———2
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.9—1——12
Show 48 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———11———112
Substance-related disordersD019966EFO_0003890F135———27
SchizophreniaD012559EFO_0000692F203———14
Drinking behaviorD004327EFO_0004315—1———12
Kidney diseasesD007674EFO_0003086N082————2
Renal insufficiencyD051437—N192————2
Psychomotor disordersD011596——1———12
SmokingD012907EFO_0004318—2————2
Dual (psychiatry) diagnosisD017831——2————2
Psychotic disordersD011618—F20.812————2
Show 18 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Sleep initiation and maintenance disordersD007319—F51.01————22
DepressionD003863—F33.9————22
ElectroencephalographyD004569——————22
MemoryD008568——————22
RehabilitationD012046——————11
HyperkinesisD006948——————11
Diabetes mellitusD003920EFO_0000400E08-E13————11
Cigarette smokingD000073865——————11
Adolescent developmentD041923——————11
Irritable bowel syndromeD043183EFO_0000555K58————11
Show 9 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use